Bio-Works Technologies
Correction: Bio-Works receives order for WorkBeads™ affimAb valued at approximately SEK 8.3 million
The order confirms continued trust from the customer and underscores Bio-Works’ strong position as a supplier of high-quality chromatography products to the biotechnology and biopharmaceutical industries.
“Receiving this repeat order from an established customer is clear proof that our products deliver on quality and performance. We are proud to continue contributing to our customers’ success in the development and production of biological drugs,” says Lone Poulsen Carlbom, CEO of Bio-Works.
WorkBeads™ affimAb is a chromatography medium developed for the purification of monoclonal antibodies (mAbs) and other protein-based drugs, where high affinity and robust performance are critical.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-10-2025 09:36 CET.
| Datum | 2025-10-17, kl 09:36 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!